Repurposing Tranexamic Acid as an Anticancer Agent

Tranexamic Acid (TA) is a clinically used antifibrinolytic agent that acts as a Lys mimetic to block binding of Plasminogen with Plasminogen activators, preventing conversion of Plasminogen to its proteolytically activated form, Plasmin. Previous studies suggested that TA may exhibit anticancer acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Mary E., Davis, Bradley J., Ghilardi, Amanda F., Yaaghubi, Elham, Dulloo, Zaafir M., Wang, Mengxiong, Guryanova, Olga A., Heldermon, Coy D., Jahn, Stephan C., Castellano, Ronald K., Law, Brian K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793890/
https://www.ncbi.nlm.nih.gov/pubmed/35095503
http://dx.doi.org/10.3389/fphar.2021.792600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793890/
https://www.ncbi.nlm.nih.gov/pubmed/35095503
http://dx.doi.org/10.3389/fphar.2021.792600

Ejemplares similares